References
1 [The epidemiological characteristics of an outbreak of 2019 novel
coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing
Bing Xue Za Zhi 2020; 41 : 145–51.
2 WHO. Coronavirus disease (COVID-19) Situation Report – 107.World Heal Organ 2020; 2019 : 2633.
3 Surveillances V. The epidemiological characteristics of an outbreak of
2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu
Xing Bing Xue Za Zhi 2020; 41 : 145–51.
4. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for
mortality of adult inpatients with COVID-19 in Wuhan, China: a
retrospective cohort study. Lancet 2020; 395: 1054–62.
5. Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics
and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs
of the Lombardy Region, Italy. JAMA 2020; published online April.
DOI:10.1001/jama.2020.5394.
6. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting
Characteristics, Comorbidities, and Outcomes Among 5700 Patients
Hospitalized With COVID-19 in the New York City Area. JAMA 2020;
published online April. DOI:10.1001/jama.2020.6775.
7. Yan Y, Yang Y, Wang F, et al. Clinical characteristics and outcomes
of patients with severe covid-19 with diabetes. BMJ open diabetes Res
care 2020; 8. DOI:10.1136/bmjdrc-2020-001343.
8. Yu Y, Xu D, Fu S, et al. Patients with COVID-19 in 19 ICUs in Wuhan,
China: a cross-sectional study. Crit Care 2020; 24: 219.
9. Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased
patients with coronavirus disease 2019: retrospective study. BMJ 2020;
368. DOI:10.1136/bmj.m1091.
10. The Australia and New Zealand Extracorporeal Membrane Oxygenation
(ANZ ECMO) Influenza Investigators. Extracorporeal membrane oxygenation
for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA.
2009;(302)
11. Noah M.A., Peek G.J., Finney S.J. Referral to an Extracorporeal
Membrane Oxygenation Center and Mortality Among Patients With Severe
2009 Influenza A(H1N1) JAMA. 2011;306:1659–1668.
12. Alshahrani M.S., Sindi A., Alshamsi F. Extracorporeal membrane
oxygenation for severe Middle East respiratory syndrome coronavirus. Ann
Intensive Care. 2018;8:3
13. Henry BM. COVID-19, ECMO, and lymphopenia: a word of caution. Lancet
Respir Med 2020; 8: e24.
14. World Health Organization. WHO Clinical management of severe acute
respiratory infection (SARI) when COVID-19 disease is suspected. Who
2020; 2019: 12.
15. Stang A: Critical evaluation of the Newcastle-Ottawa scale for the
assessment of the quality of nonrandomized studies in meta-analyses. Eur
J Epidemiol 2010, 25: 603-605.
16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control
Clin Trials 1986;7:177-88.
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring
inconsistency in meta-analyses. BMJ. 2003;327: 557–560.
18. Zhou, Ning and Wang, Luyun and Jiang, Jiangang and Cheng, Peng and
Cui, Guanglin and Wang, Feng and Guan, Zhimin and Zhang, Panpan and Li,
Shengqing and Wen Wang, Dao, Application of ECMO Successfully Treated
Critically Ill COVID-19 Patients (4/1/2020). Available at SSRN:
https://ssrn.com/abstract=3569889
19. Zhang G, Hu C, Luo L, et al. Clinical Features and Treatment of 221
Patients with COVID-19 in Wuhan, China. SSRN Electron J 2020.
DOI:10.2139/ssrn.3546095.
20. Takeda S. Nationwide system to centralize decisions around ECMO use
for severe COVID-19 pneumonia in Japan. Acute Med Surg 2020; 4: 20–1.
21. Jacobs JP, Stammers AH, St Louis J, et al. Extracorporeal Membrane
Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise
in COVID-19: Experience with 32 patients. ASAIO J 2020.
DOI:10.1097/MAT.0000000000001185.
22. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of
critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a
single-centered, retrospective, observational study. Lancet Respir Med
2020; 2600: 1–7.
23. Ruan Q, Yang K, Wang W, Jiang L, Song J. Correction to: Clinical
predictors of mortality due to COVID-19 based on an analysis of data of
150 patients from Wuhan, China (Intensive Care Medicine, (2020),
10.1007/s00134-020-05991-x). Intensive Care Med 2020.
DOI:10.1007/s00134-020-06028-z.
24. Li X, Guo Z, Li B, et al. Extracorporeal Membrane Oxygenation for
Coronavirus Disease 2019 in Shanghai, China. ASAIO J 2020; : 1.
25. Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus
disease 2019 in China. N Engl J Med 2020; 382: 1708–20.
26. Zeng Y, Cai Z, Xianyu Y, Yang BX, Song T, Yan Q. Prognosis when
using extracorporeal membrane oxygenation (ECMO) for critically ill
COVID-19 patients in China: a retrospective case series. Crit Care 2020;
24: 148.
27. Beyls C, Huette P, Abou-Arab O, Berna P, Mahjoub Y. Extracorporeal
membrane oxygenation for COVID-19-associated severe acute respiratory
distress syndrome and risk of thrombosis. Br J Anaesth 2020; : 1–3.
28. Osho AA, Moonsamy P, Hibbert KA, et al. Veno-venous Extracorporeal
Membrane Oxygenation for Respiratory Failure in COVID-19 Patients: Early
Experience From a Major Academic Medical Center in North America. Ann
Surg 2020; : 440–53.
29. Haye G, Fourdrain A, Abou-Arab O, Berna P, Mahjoub Y. COVID-19
outbreak in France: Setup and activities of a mobile Extra Corporeal
Membrane Oxygenation (ECMO) team during the first 3 weeks. J
Cardiothorac Vasc Anesth 2020; 000: 8–10.
30. Ñamendys-Silva SA. ECMO for
ARDS due to COVID-19. Heart Lung. 2020 Mar 26:S0147-9563(20)30100-X.
doi: 10.1016/j.hrtlng.2020.03.012. Epub ahead of print.
31. Henry BM, Lippi G. Poor survival with extracorporeal membrane
oxygenation in acute respiratory distress syndrome (ARDS) due to
coronavirus disease 2019 (COVID-19): Pooled analysis of early reports. J
Crit Care. 2020 Apr 1;58:27-28.
32. Barbaro RP, Odetola FO, Kidwell KM, Paden ML, Bartlett RH, Davis MM,
Annich GM. Association of hospital-level volume of extracorporeal
membrane oxygenation cases and mortality: analysis of the Extracorporeal
Life Support Organization Registry. Am J Respir Crit Care Med
2015;191:894–901.
33. Force ARDSDT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND,
Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress
syndrome: the Berlin definition. JAMA. 2012.
34. Gattinoni, L., Chiumello, D.
& Rossi, S. COVID-19 pneumonia: ARDS or not? 2020. Crit Care 24, 154 .
35. Yin S, Huang M, Li D, Tang N. Difference of coagulation features
between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J
Thromb Thrombolysis. 2020. ahead of print
36. Fina D, Matteucci M, Jiritano F, Meani P, Lo Coco V, Kowalewski M,
Maessen J, Guazzi M, Ballotta A, Ranucci M, Lorusso R. Extracorporeal
membrane oxygenation without therapeutic anticoagulation in adults: a
systematic review of the current literature. Int J Artif Organs.
2020:391398820904372. ahead of print.
37. ELSO COVID-19 interim guidelines. ELSO, 2020 (Available from
www.elso.org)
38. Munshi L, Walkey A, Goligher E, Pham T, Uleryk EM, Fan E. Venovenous
extracorporeal membrane oxygenation for acute respiratory distress
syndrome: a systematic review and meta-analysis. Lancet Respir Med.
2019;7(2):163‐172.
39. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ,
HLH Across Specialty Collaboration, UK. COVID-19: consider cytokine
storm syndromes and immunosuppression. Lancet. 2020 Mar 28;
395(10229):1033-1034.
40. Abrams D, Ferguson ND, Brochard L, Fan E, Mercat A, Combes A,
Pellegrino V, Schmidt M, Slutsky AS, Brodie D. ECMO for ARDS: from
salvage to standard of care? Lancet Respir Med. 2019 Feb; 7(2):108-110.